NUProtein
Tokushima
About NUProtein
NUProtein has introduced a protein synthesis technology that is 100x more cost effective, 24x smaller and 30x faster than current GMO solutions; representing a significant disruption for the $146B combined market. We are targeting large scale protein production for the medical and food additive protein market. Through the introduction of our alternative meat and cultured meat solutions we can positively impact health epidemics and increase worldwide food security.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (Mar 2020)
- Website: nuprotein.jpen
- Phone: +81-088-677-9226
Industries & Categories
Alternative Protein, Biotechnology, Wellness
Social Profiles
Canonical: https://fsome.com/organization/nuprotein-186851 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.